May 8, 2025 at 1PM EST

The pharmaceutical landscape is undergoing a profound transformation, marked by significant regulatory shifts and the imperative for enhanced cross-functional effectiveness. This webinar provides a comprehensive analysis of the impact of 340B regulations and the Inflation Reduction Act (IRA) on pharmaceutical revenue and pricing strategies. Our industry experts explored the intricacies of these legislative changes and their implications for manufacturers and healthcare providers. 

• Understand the financial implications of the 340B and IRA regulations.

• Analyze product archetypes to inform strategic business decisions.

• Develop effective pricing strategies in a changing regulatory environment.

• Enhance cross-functional collaboration to maximize impact.

Learn how to connect the dots and make informed decisions in today’s complex landscape.

Jen Sharpe
Vice President, GTN Advisory

Walt Worsham
Managing Director